logo

Bristol-Myers Squibb Co. (BMY)



Trade BMY now with
  Date
  Headline
9/5/2019 7:08:03 AM Bristol-Myers Squibb Updates On Phase 3 Opdivo CheckMate -548 Trial
9/4/2019 7:02:33 AM BioMotiv And Bristol-Myers Squibb Form Strategic Partnership
8/27/2019 8:03:15 AM Presage Enters Research Collaboration With Bristol-Myers To Evaluate Early Stage Oncology Targets In Phase 0 Trials
8/26/2019 6:32:26 AM Amgen To Acquire Otezla For $13.4 Bln In Cash
8/5/2019 8:03:12 AM PTC Therapeutics Signs Long-term Lease Agreement With Bristol-Myers Squibb
8/1/2019 7:24:38 AM Nektar, Bristol-Myers Announce FDA Breakthrough Therapy Designation For NKTR-214 In Combination With Opdivo
7/26/2019 7:10:31 AM Bristol-Myers Squibb Gets Positive CHMP Opinion Regarding Approval Of Empliciti
7/25/2019 9:25:54 AM Bristol-Myers Squibb Co. (BMY) Has Raised Its 2019 EPS Estimate To 4.20 - 4.30 From 4.10 - 4.20
7/25/2019 7:04:28 AM Bristol-Myers Squibb Q2 Non-GAAP EPS $1.18 Vs $1.01 Last Year
7/24/2019 4:23:21 PM Bristol-Myers Squibb Says Part 2 Of Phase 3 CheckMate -227 Trial Did Not Meet Primary Endpoint
  
 
>